Overall Survival

Vitamins Can Affect How Well Immunotherapy Works

Mesothelioma treatment is an intricate field where even the tiniest factors can play a huge role. Recently, scientists discovered something unexpected: a connection between vitamin B12 and how well certain cancer treatments work. Cancer treatments that boost the immune system, often called immunotherapy, are great ways to treat hard to[…]

Read More »

Mesothelioma Survival Times Based on Asbestos Exposure Levels

Malignant mesothelioma is a tough cancer to treat. Even with a short survival time, some people with this cancer live longer than expected. A recent study in a science journal called Toxics looked at patients with mesothelioma and asbestos-related lung cancer. All of them had been around asbestos between 2009[…]

Read More »

Mesothelioma Survival Times Based on Asbestos Exposure Levels

Malignant mesothelioma is a tough cancer to treat. Even with a short survival time, some people with this cancer live longer than expected. A recent study in a science journal called Toxics looked at patients with mesothelioma and asbestos-related lung cancer. All of them had been around asbestos between 2009[…]

Read More »

Using Technology to Understand the Genetics of Mesothelioma

A new study used advanced technology to understand the genetic details of mesothelioma. New results are pointing to potential ways to personalize treatment for this rare and aggressive cancer. Mesothelioma is a cancer of the thin membrane that surrounds different organs and areas of the body. It is caused by[…]

Read More »

3D Printing and Optical Scanning Could Help Mesothelioma Treatment

New technologies offer hope for more effective treatments for malignant pleural mesothelioma and other hard-to-treat cancers. One innovation is the use of 3D printing and optical scanning. These new technologies refine photodynamic therapy, a promising approach for mesothelioma management. Photodynamic therapy uses the power of light to target and destroy[…]

Read More »

Ipilimumab and Nivolumab Can Improve Survival in Mesothelioma Patients

Mesothelioma is a rare and tough cancer to treat and is usually linked to asbestos exposure. Scientists are continually exploring new ways to treat it, and one promising method is using the combination of the two drugs nivolumab and ipilimumab. A new study looks at what these drugs do and[…]

Read More »

Mesothelin Could Be Used to Improve Mesothelioma Treatment

Mesothelioma is a hard cancer to treat and understand. Understanding protein expressed by mesothelioma cells could potentially help. This protein may be a clue to the cancer, but an easier way to check for it in a lab needs to be found. In the study, scientists dig into mesothelin, see[…]

Read More »

Radiomics Can Be Used to Improve Mesothelioma Treatment

Malignant mesothelioma is a challenging cancer to treat. New therapies like T cell receptor fusion constructs (TRuCs) show promise. Identifying which patients will benefit from these treatments is important. Radiomics, a field that extracts data from medical images, offers a potential solution. Radiomics may predict treatment responses based on imaging[…]

Read More »

Recurring Collapsed Lung Could Indicate Mesothelioma

A new article highlights the link between a collapsed lung and mesothelioma. Mesothelioma, caused by asbestos exposure, can present unexpectedly due to its long latency period. It often requires many clinical tests for accurate diagnosis and treatment planning. A new study explores the case of a 73-year-old man whose recurrent[…]

Read More »

A Type of T Cell Therapy is Showing Promising Results for Mesothelioma

A clinical trial testing a new type of cell therapy for mesothelioma is actively recruiting patients at sites across the country, including Moffitt Cancer Center in Tampa, Florida. The trial is early stage. The therapy, called Synkir-110, is a lab-engineered cell treatment designed to target mesothelin, a protein found on[…]

Read More »

Skip to content